Cyclosporine in systemic sclerosis. results of a forty-eight–week open safety study in ten patients-Reference-Cited by-同舟云学术

Cyclosporine in systemic sclerosis. results of a forty-eight–week open safety study in ten patients

Published:1993-01 Issue:1 Volume:36 Page:75-83
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Clements Philip J.,Lachenbruch Peter A.,Sterz Mildred,Danovitch Gabriel,Hawkins Randall,Ippoliti Andrew,Paulus Harold E.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference17 articles.

1. : Scleroderma, Textbook of Rheumatology. Third edition. Edited by , , . Philadelphia, WB Saunders, 1989

2. Soluble interleukin-2 receptors in patients with systemic sclerosis

3. , : Nephrotoxicity and hypertension in patients with autoimmune disease treated with cyclosporine, Cyclosporine: Applications in Autoimmune Diseases. Edited by Philadelphia, Grune and Stratton, 1988

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach;Expert Review of Clinical Immunology;2024-02-26

2. Calcineurin inhibitors in systemic sclerosis – a systematic literature review;Therapeutic Advances in Musculoskeletal Disease;2022-01

3. Journey of a patient with scleroderma from renal failure up to kidney transplantation;World Journal of Transplantation;2021-09-18

4. Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?;International Journal of Molecular Sciences;2019-09-04

5. British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018;British Journal of Dermatology;2019-06